The Clinical-Grade
Compound Database.

For decades, the “insurance policy” of a daily multivitamin has dominated the supplement industry. Massive-scale clinical reviews, however, paint an entirely different picture: antagonistic absorption, downregulated endogenous synthesis, and a critical importance of targeted dosing now define the conversation.

We analyze the metabolic pathways that prove why less, when targeted, is vastly more effective. The post-genomic era demands precision; the era of broad-stroke supplementation, by every indication available, is closing.

Cross-references in the database now thread Magnesium L-Threonate, Urolithin A, and Spermidine into a coherent picture of cellular maintenance.